We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$412M
AUM Growth
+$70.8M
Cap. Flow
+$36.5M
Cap. Flow %
8.87%
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234

Top Buys

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$1.67M
2
DCI icon
Donaldson
DCI
+$1.6M
3
FDX icon
FedEx
FDX
+$1.6M
4
FNF icon
Fidelity National Financial
FNF
+$1.53M
5
GGG icon
Graco
GGG
+$1.51M

Top Sells

Rank Stock Value
1
CDNS icon
Cadence Design Systems
CDNS
+$1.48M
2
TIC
TIC Solutions Inc
TIC
+$1.48M
3
SDGR icon
Schrodinger
SDGR
+$1.27M
4
EXC icon
Exelon
EXC
+$1.23M
5
VC icon
Visteon
VC
+$1.22M

Sector Composition

Rank Sector Weight
1 Industrials 18.1%
2 Financials 16.8%
3 Healthcare 15.07%
4 Technology 12.86%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SATL icon
701
Satellogic
SATL
$713M
$185K 0.04%
32,372
STTK icon
702
Shattuck Labs
STTK
$681M
$183K 0.04%
+26,387
New +$165K
BGC icon
703
BGC Group
BGC
$5.79B
$183K 0.04%
+17,129
New +$192K
ULH icon
704
Universal Logistics Holdings
ULH
$501M
$182K 0.04%
+12,312
New +$220K
OLMA icon
705
Olema Pharmaceuticals
OLMA
$941M
$181K 0.04%
+14,454
New +$194K
NNDM
706
Nano Dimension
NNDM
$342M
$181K 0.04%
124,568
+55,705
+81% +$91K
SXC icon
707
SunCoke Energy
SXC
$877M
$177K 0.04%
21,971
-22,073
-50% -$171K
GERN icon
708
Geron
GERN
$1.01B
$176K 0.04%
137,644
+38,570
+39% +$54.3K
ANNX icon
709
Annexon
ANNX
$923M
$176K 0.04%
30,787
-20,634
-40% -$114K
LMNR icon
710
Limoneira
LMNR
$272M
$175K 0.04%
13,291
+2,718
+26% +$35K
MDXG icon
711
MiMedx Group
MDXG
$666M
$173K 0.04%
44,915
+257
+0.6% +$938
DXC icon
712
DXC Technology
DXC
$1.86B
$171K 0.04%
19,310
ZURA icon
713
Zura Bio
ZURA
$597M
$170K 0.04%
+28,806
New +$137K
NMR icon
714
Nomura Holdings
NMR
$31.1B
$170K 0.04%
19,336
-55,837
-74% -$464K
BVS icon
715
Bioventus
BVS
$961M
$167K 0.04%
17,732
-5,696
-24% -$54.4K
PALI icon
716
Palisade Bio
PALI
$364M
$164K 0.04%
78,498
-997
-1% -$1.96K
XRAY icon
717
Dentsply Sirona
XRAY
$2.27B
$164K 0.04%
+15,426
New +$168K
MVST icon
718
Microvast
MVST
$266M
$163K 0.04%
139,729
+17,241
+14% +$26.6K
CABA icon
719
Cabaletta Bio
CABA
$588M
$158K 0.04%
+50,927
New +$167K
GDRX icon
720
GoodRx Holdings
GDRX
$1.19B
$156K 0.04%
+54,271
New +$138K
GRNT icon
721
Granite Ridge Resources
GRNT
$670M
$156K 0.04%
+35,386
New +$186K
STNE icon
722
StoneCo
STNE
$2.33B
$155K 0.04%
14,298
VOD icon
723
Vodafone
VOD
$39.1B
$155K 0.04%
11,699
ADMA icon
724
ADMA Biologics
ADMA
$2.15B
$152K 0.04%
18,144
-65,817
-78% -$600K
SFIX
725
Stitch Fix
SFIX
$407M
$150K 0.04%
36,413
-9,112
-20% -$33.1K

Similar funds

EntryPoint Capital's Q2 2026 Portfolio in Review

As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.

  • EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
  • EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
  • EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
  • EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
  • EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
  • EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
  • EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.